» Articles » PMID: 38453930

Medication Adherence Halves COPD Patients' Hospitalization Risk - Evidence from Swiss Health Insurance Data

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Medication adherence is vital for patients suffering from Chronic Obstructive Pulmonary Disease (COPD) to mitigate long-term consequences. The impact of poor medication adherence on inferior outcomes like exacerbations leading to hospital admissions is yet to be studied using real-world data. Using Swiss claims data from 2015-2020, we group patients into five categories according to their medication possession ratio. By employing a logistic regression, we quantify each category's average treatment effect of the medication possession ratio on hospitalized exacerbations. 13,557 COPD patients are included in the analysis. Patients with high medication adherence (daily medication reserve of 80% to 100%) are 51% less likely to incur exacerbation following a hospital stay than patients with the lowest medication adherence (daily medication reserve of 0% to 20%). The study shows that medication adherence varies strongly among Swiss COPD patients. Furthermore, high medication adherence immensely decreases the risk of hospitalized exacerbations.

Citing Articles

Adherence to Inhalation Therapy Among COPD Patients: A Cross-Sectional Study in a Tertiary Hospital in Quito, Ecuador.

Izquierdo-Condoy J, Gualpa Alvarez F, Morales-Lapo E, Arias Calvache W, Bermudez Moreira J, Quinga-Chiguano K Int J Chron Obstruct Pulmon Dis. 2025; 20:399-410.

PMID: 40008110 PMC: 11853065. DOI: 10.2147/COPD.S493992.


A Qualitative Study on Illness Perception and Coping Behaviors Among Patients with Chronic Obstructive Pulmonary Disease: Implications for Intervention.

Huang L, Tan C, Chen X, Jiang Y, Zhou Y, Zhao H Int J Chron Obstruct Pulmon Dis. 2024; 19:2467-2479.

PMID: 39583958 PMC: 11584336. DOI: 10.2147/COPD.S473790.

References
1.
Demeyer H, Louvaris Z, Frei A, Rabinovich R, de Jong C, Gimeno-Santos E . Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial. Thorax. 2017; 72(5):415-423. PMC: 5520265. DOI: 10.1136/thoraxjnl-2016-209026. View

2.
Davis J, Wu B, Kern D, Tunceli O, Fox K, Horton J . Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population. Am Health Drug Benefits. 2017; 10(2):92-102. PMC: 5470247. View

3.
Donaldson G, Seemungal T, Bhowmik A, Wedzicha J . Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002; 57(10):847-52. PMC: 1746193. DOI: 10.1136/thorax.57.10.847. View

4.
Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala J, Masa F . Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004; 59(5):387-95. PMC: 1746989. DOI: 10.1136/thx.2003.008730. View

5.
Vestbo J, ANDERSON J, Calverley P, Celli B, Ferguson G, Jenkins C . Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009; 64(11):939-43. DOI: 10.1136/thx.2009.113662. View